Fundz

Innoforce Strengthens Commercialization Leadership and Announces the Appointment of a New Chief Executive Officer

PRIVATEAug 01, 2023

Position

Chief Executive Officer

Company

Innoforce

Dewan Zeng
dewan.zeng@innoforcepharma.com
HangzhouBiotechnologyScience And Engineering

Description

Zhejiang Innoforce Pharmaceuticals Co., Ltd. , a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy Medicinal Product customers and partners, today announced Dr. Dewan Zeng as the new Chief Executive Officer, effective immediately

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Innoforce, and when

A new leader at Innoforce brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Innoforce raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Innoforce, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Innoforce. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Innoforce

Location

Hangzhou, Zhejiang, China

About

Innoforce is a partnership-focused biopharmaceutical company established to enable and accelerate the innovation of breakthrough medicines. The company has world-class biopharmaceutical manufacturing and development capabilities to serve global markets at our campus in Hangzhou, China, and offices in Rockville, Maryland. Innoforce offers end-to-end contract development and manufacturing service (CDMO), including GMP manufacturing of plasmid DNA, RNA, viral vector, and cell products by the middle of 2022. In addition, through a joint venture with a leading international supplier of life sciences products & services, the company provides CDMO services for antibody and protein drugs. Innoforce's enabling capabilities for incubating and developing cell, gene, and advanced biological therapies can support partners and portfolio companies to rapidly and efficiently bring cutting-edge treatments that impact patients' lives worldwide. More information is available at www.innoforcepharma.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Innoforce changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dewan
Likely contact at this company
••••••••@••••••••

See Dewan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Innoforce's next move

Learn about Strategic plan

Innoforce changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.